WEDNESDAY, Nov. 27, 2024 (HealthDay News) — President-elect Donald Trump has tapped Dr. Jay Bhattacharya, a Stanford health economist and critic of pandemic lockdowns and vaccine mandates, to lead the nation’s largest medical research agency, the National Institutes of Health. In a statement late Tuesday, Trump said Bhattacharya will workContinue Reading

WEDNESDAY, Nov. 27, 2024 (HealthDay News) — The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found. Zepbound reduced the risk of diabetes in obese prediabetic patients by more than 90% during a three-year period compared to placebo, trial resultsContinue Reading